Hepatitis C Therapy - Valeant hepatitis C drug misses goal, shares dive

Valeant hepatitis C drug misses goal, shares dive
Reuters - Mar 21, 2006... Valeant Pharmaceuticals International (VRX.N: Quote, Profile, Research) said on Tuesday a late-stage trial of its chronic hepatitis C treatment Viramidine was ...

Barron's(3/27) Research Reports: How Analysts -2-
Therapeutics Daily (subscription) (press release), PA - Mar 25, 2006Viramidine [a drug for treating chronic hepatitis C in treatment-naive patients] did not meet the non-inferiority efficacy endpoint on an overall intent-to ...

Researchers show laboratory hepatitis C strain is also infectious ...
The Rockefeller University Newswire, NY - Mar 27, 2006... involved a strain of mice called uPA-SCID, which lack an immune system and mimic the liver failure that can accompany chronic hepatitis C infection in people. ...

Clinical Study Results of Actilon for Hepatitis C
EndoNurse, AZ - Mar 21, 2006... clinical study of Actilon (CPG 10101) in combinations with pegylated interferon and/or ribavirin for the treatment of chronic hepatitis C virus (HCV) in the ...

Novelos Therapeutics Closes $15 Million Private Placement
International News Service, Australia - Mar 7, 2006... NOV-002 in lung cancer, in addition to our other clinical development programs, including chemotherapy-resistant ovarian cancer and chronic hepatitis C with NOV ...

AVI BioPharma Successful Ebola Study Results Highlighted in Nature ...
Genetic Engineering News, NY - Mar 7, 2006... infections.". AVI is currently enrolling patients with chronic hepatitis C infection in a Phase I/II clinical trial in the United States. ...